Your browser doesn't support javascript.
loading
Association of OPRD1 Gene Variants with Changes in Body Weight and Psychometric Indicators in Patients with Eating Disorders.
González-Rodríguez, Laura; González, Luz María; García-Herráiz, Angustias; Mota-Zamorano, Sonia; Flores, Isalud; Gervasini, Guillermo.
Afiliação
  • González-Rodríguez L; Department of Medical & Surgical Therapeutics, Medical School, University of Extremadura, 06006 Badajoz, Spain.
  • González LM; Department of Medical & Surgical Therapeutics, Medical School, University of Extremadura, 06006 Badajoz, Spain.
  • García-Herráiz A; Eating Disorders Unit, Health Service of Extremadura, 06010 Badajoz, Spain.
  • Mota-Zamorano S; Department of Medical & Surgical Therapeutics, Medical School, University of Extremadura, 06006 Badajoz, Spain.
  • Flores I; Institute of Molecular Pathology Biomarkers, University of Extremadura, 06010 Badajoz, Spain.
  • Gervasini G; Eating Disorders Unit, Health Service of Extremadura, 06010 Badajoz, Spain.
J Clin Med ; 13(17)2024 Sep 01.
Article em En | MEDLINE | ID: mdl-39274402
ABSTRACT

Objectives:

This study aimed to investigate whether genetic variations in the OPRD1 gene affect psychopathological symptoms and personality dimensions in eating disorders (ED) patients and/or contribute to ED risk.

Methods:

The study involved 221 female patients with anorexia nervosa (AN), 88 with bulimia nervosa (BN), and 396 controls. Sixteen tag-single nucleotide polymorphisms (SNPs) in OPRD1 were identified. Psychometric evaluations were conducted using the Symptom Checklist 90 Revised (SCL-90R) and the Eating Disorders Inventory Test-2 (EDI-2). p-values obtained by regression models were corrected for multiple testing by the False Discovery Rate (FDR) method.

Results:

In AN patients, genotypes rs204077TT and rs169450TT were linked to lower body-mass index (BMI) values (FDR-q = 0.035 and 0.017, respectively), as was rs2234918 in a log-additive model (BMI 18.0 ± 0.28, 17.22 ± 0.18 and 16.59 ± 0.39 for TT, TC and CC carriers, FDR-q = 0.012). Additionally, AN patients carrying the rs72665504AA genotype had higher scores in interpersonal distrust (FDR-q = 0.030), whilst BN carriers of rs513269TT and rs2873795TT showed lower scores in ineffectiveness (FDR-q = 0.041 and FDR-q = 0.021). In the AN group, BMI correlated with variability in a distal haplotype (rs508448/rs204077/rs223491, FDR-q = 0.028), which was also associated with the global positive symptom total (PST) index of SCL-90R (FDR-q = 0.048). Associations were more noticeable in BN patients; again, the distal region of the gene was linked to EDI-2 total scores (FDR-q = 0.004-0.048 for the four last haplotypes) and two global SCL-90R indices (GSI FDR-q = 0.011 and positive symptom distress index (PSDI) FDR-q = 0.003 for the last s204077/rs2234918/rs169450 combination). No associations with ED risk were observed.

Conclusions:

Genetic variation in the OPRD1 gene, particularly in its distal region, is associated with BMI and psychopathological comorbidities in ED patients.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article